We love to hear from our listeners. Send us a message.
Kristin Yarema, Ph.D., CEO, Poseida Therapeutics sits down with Cell & Gene: The Podcast Host Erin Harris to discuss four of the biggest challenges the CGT sector faces when it comes to the development of off-the-shelf therapies. Kristin shares how 2024 might see some real progress in allogeneic therapies.
Developing an mRNA Therapy for DMD with Elixirgen Therapeutics' Aki Ko
The Current State of the Global Regulatory Landscape with ISCT's Dr. Bambi Grilley
Dr. Bruce Levine on ISCT and the Future of CAR-T
CGTs for HIV Suppression with Addimmune's Dr. Marcus Conant
Inside BlueRock Therapeutics' Parkinson's Disease Trial with Dr. Ahmed Enayetallah
Reducing the Disease Burden of AML with Vor Bio's Dr. Robert Ang
Reducing Toxicities in Allogeneic Cell Therapies with Orca Bio's Dr. Scott McClellan
Inside Cellular Rejuvenation Therapies for Age-Related Diseases with Life Biosciences' Sharon Rosenzweig-Lipson, Ph.D.
The Future of Rare Diseases with The Jackson Laboratory’s Rare Disease Translational Center's Cat Lutz
Inside Yescarta's Reduced Median Turnaround Time with Kite, a Gilead company's Christopher McDonald
Pricing, Value, And Access of CGTs With The Dedham Group's Jennifer Klarer, M.Sc.Eng.
Breaking Down Solid Tumors with Triumvira Immunologics' Dr. Paul Lammers
Cell Therapy For Corneal Endothelial Dystrophies With Aurion Biotech's Greg Kunst
Overcoming the Limitations of CAR T-Cell Therapy with Vittoria Bio's Nick Siciliano, Ph.D.
Gene Therapy Deals, Collaborations, & Partnerships with Astellas' Richard Wilson
The Promise of AAV Gene Therapy with REGENXBIO's Ken Mills
Inside 2023 Meeting on the Mesa with ARM's COO, Rita Johnson-Greene
The Future of Cell and Organ Transplantation in Treating T1D with Dr. Camillo Ricordi
In Vivo CAR T-Cell Therapeutics With Umoja Biopharma's Dr. Andrew Scharenberg
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Short Wave
Unexplainable
Stuff To Blow Your Mind
Speaking of Psychology